Price Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads â just like side effects.
Drug Costs
381-400 of 705 results
-
-
The Money And Politics Of Prescription Drugs: What You Need To Know
America spends about as much on prescription drugs as all the revenues of the three big car makers combined. Tracking where the money goes is hard. PolitiFact has some charts to help.
-
Drug Industry Patents Go Under Senate Judiciary Committeeâs Microscope
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
By Rachel Bluth -
Is Insulin’s High Cost Keeping Diabetes Patients From Taking Their Medicine?
An estimated 1.25 million Americans have Type 1 diabetes and cannot live without insulin. Sen. Kamala Harrisâ claim that 1 in 4 diabetes patients cannot afford their insulin is a shockingly high number, so we decided to dig into the sparse data.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Newsom: California Leads On Prescription Drugs
California Gov. Gavin Newsom claims that his state is âleading the nation in holding drug companies accountable and fighting prescription drug prices.â Is that really the case?
-
Klobuchar Wants To Stop âPay-For-Delayâ Deals That Keep Drug Prices High
Itâs as shady as it sounds.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
-
Mulvaney: Trump Brought Down Drug Prices For The First Time In 50 Years
Itâs "within spitting distance of something thatâs true," said one health economist. But our fact check found it wasn't quite there.
-
Podcast: KHNâs âWhat The Health?â Still More âMedicare-For-Allâ
Sarah Kliff of Vox.com, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post join KHNâs Julie Rovner to discuss the latest version of a âMedicare-for-allâ bill by Sen. Bernie Sanders (I-Vt.), a presidential hopeful, and Democratic and Republican reactions to it. They also discuss the latest on congressional efforts to rein in drug prices and another state effort to expand Medicaid â but not exactly in the way voters wanted. Also, Rovner interviews Ceci Connolly of the Alliance of Community Health Plans.
-
The Blame Game: Everyone And No One Is Raising Insulin Prices
During Wednesdayâs House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decadeâs 300% price increase, frustrating congressional representatives.
By Rachel Bluth -
Can Someone Tell Me What A PBM Does?
The Senate Finance Committeeâs third drug-pricing hearing focused on pharmacy benefit managers, and was more of a fact-finding mission on how these companies operate than a debate about policy proposals.
By Rachel Bluth -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
-
Analysis: Why Americans Shouldnât Feel Grateful For $137 Insulin
Only by the bizarre logic of the U.S. pharmaceutical industry does this drug count as any kind of generic.
-
Must-Reads Of The Week (Some Flying Below The Radar)
Executive editor Damon Darlin takes a spin as host of âThe Friday Breeze,â whirling through a week of health care news so you donât have to.
By Damon Darlin -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
-
Podcast: KHNâs âWhat The Health?â The Karma Of Cutting Medicare
Stephanie Armour of The Wall Street Journal, Alice Ollstein of Politico and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss the suggested cuts to health programs in President Donald Trumpâs budget proposal, the latest on lawsuits challenging work requirements for Medicaid enrollees and the FDAâs crackdown on e-cigarettes. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
-
How Much Difference Will Eli Lilly’s Half-Price Insulin Make?
Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.